- Home
- IVDA vs JAGX Comparison
IVDA vs JAGX Comparison
Compare IVDA & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- JAGX
- Stock Information
- Founded
- IVDA 2003
- JAGX 2013
- Country
- IVDA United States
- JAGX United States
- Employees
- IVDA N/A
- JAGX N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- JAGX Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- JAGX Health Care
- Exchange
- IVDA Nasdaq
- JAGX Nasdaq
- Market Cap
- IVDA 4.3M
- JAGX 3.9M
- IPO Year
- IVDA N/A
- JAGX N/A
- Fundamental
- Price
- IVDA $1.58
- JAGX $2.12
- Analyst Decision
- IVDA
- JAGX Strong Buy
- Analyst Count
- IVDA 0
- JAGX 1
- Target Price
- IVDA N/A
- JAGX $60.00
- AVG Volume (30 Days)
- IVDA 5.5M
- JAGX 170.1K
- Earning Date
- IVDA 11-13-2025
- JAGX 11-12-2025
- Dividend Yield
- IVDA N/A
- JAGX N/A
- EPS Growth
- IVDA N/A
- JAGX N/A
- EPS
- IVDA N/A
- JAGX N/A
- Revenue
- IVDA $7,142,302.00
- JAGX $11,810,000.00
- Revenue This Year
- IVDA $340.48
- JAGX $22.41
- Revenue Next Year
- IVDA N/A
- JAGX $30.00
- P/E Ratio
- IVDA N/A
- JAGX N/A
- Revenue Growth
- IVDA 88.96
- JAGX 15.96
- 52 Week Low
- IVDA $1.15
- JAGX $1.57
- 52 Week High
- IVDA $8.05
- JAGX $33.50
- Technical
- Relative Strength Index (RSI)
- IVDA 50.34
- JAGX 53.78
- Support Level
- IVDA $1.46
- JAGX $2.08
- Resistance Level
- IVDA $2.24
- JAGX $2.44
- Average True Range (ATR)
- IVDA 0.17
- JAGX 0.16
- MACD
- IVDA 0.04
- JAGX 0.02
- Stochastic Oscillator
- IVDA 37.62
- JAGX 50.81
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.